Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I-Reference-Cited by-同舟云学术

Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I

Published:2003-09-18 Issue:4 Volume:59 Page:487-491
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Shaw N. J.,Fraser N. C.,Rose S.,Crabtree N. J.,Boivin C. M.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2003.01875.x/fullpdf

Reference26 articles.

1. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency;Bachrach;Journal of Bone & Mineral Research,1998

2. Therapy for 6·5-7·5 years with recombinant Insulin-like growth factor 1 in children with growth hormone insensitivity syndrome: a clinical research centre study;Backeljauw;Journal of Clinical Endocrinology and Metabolism,2001

3. Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity;Bjarnason;Clinical Endocrinology,2002

4. Statistical methods for assessing agreement between two methods of clinical measurement;Bland;Lancet,1986

5. Determination of body composition of children from skinfold measurements;Brook;Archives of Disease in Childhood,1971

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis;Nature Reviews Endocrinology;2022-03-14

2. rhIGF-1 Treatment Increases Bone Mineral Density and Trabecular Bone Structure in Children with PAPP-A2 Deficiency;Hormone Research in Paediatrics;2018

3. Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density;The Journal of Clinical Endocrinology & Metabolism;2017-09-28

4. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome;Mutation Research/Reviews in Mutation Research;2017-04

5. Effectiveness of Recombinant Human Growth Hormone for Pharyngocutaneous Fistula Closure;Clinical and Experimental Otorhinolaryngology;2015